Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Rang în acțiuni #14767
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Preț acțiune
$16.85
Ultima sincronizare: 2023-07-07
Capitalizare de piață
$393.50M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
CH
Tranzacționează VectivBio Holding AG (VECT)

Categorie

Istoric al prețului acțiunii pentru VectivBio Holding AG (VECT)
Cel mai mare preț de închidere: $16.72 pe 2023-07-01

Cel mai mic preț de închidere: $16.68 pe 2021-04-01
Istoric al prețului acțiunii pentru VectivBio Holding AG din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2023 96.64%
2022 112.95%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$745.22 4.45%
CH